Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASTOR: Prednisone for Cardiac Sarcoidosis
NCT01210677Phase 4Withdrawn
- Sponsor
- University of Ottawa Heart Institute
- Start
- Apr 2014
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisone in cardiac sarcoidosis (CS), sponsored by University of Ottawa Heart Institute. Planned start Apr 2014; status: withdrawn.
02
Drugs
prednisone
03
Conditions
cardiac sarcoidosis (CS)
Beyond the preview
Go deeper on NCT01210677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01210677.